| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of Clinically Relevant Pharmacokinetic Interaction Between Ribavirin and Tenofovir in Healthy Subjects
|
Ramanathan, Srinivasan
|
|
2006
|
46 |
5 |
p. 559-566
|
artikel
|
| 2 |
Clinical Evaluation of QT/QTc Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 Guideline
|
Darpo, Borje
|
|
2006
|
46 |
5 |
p. 498-507
|
artikel
|
| 3 |
CYP2D6 Genotype and Phenotype in Amerindians of Tepehuano Origin and Mestizos of Durango, Mexico
|
Sosa-Macías, Martha
|
|
2006
|
46 |
5 |
p. 527-536
|
artikel
|
| 4 |
Development of a Predictive Pharmacokinetic Model for a Novel Cyclooxygenase-2 Inhibitor
|
Kastrissios, H.
|
|
2006
|
46 |
5 |
p. 537-548
|
artikel
|
| 5 |
Effect of Food, an Antacid, and the H2 Antagonist Ranitidine on the Absorption of BAY 59-7939 (Rivaroxaban), an Oral, Direct Factor Xa Inhibitor, in Healthy Subjects
|
Kubitza, Dagmar
|
|
2006
|
46 |
5 |
p. 549-558
|
artikel
|
| 6 |
Evaluation of the Drug Interaction Potential of Aplaviroc, a Novel Human Immunodeficiency Virus Entry Inhibitor, Using a Modified Cooperstown 5 + 1 Cocktail
|
Johnson, Brendan M.
|
|
2006
|
46 |
5 |
p. 577-587
|
artikel
|
| 7 |
Pharmacokinetics of Buspirone in Autistic Children
|
Edwards, David J.
|
|
2006
|
46 |
5 |
p. 508-514
|
artikel
|
| 8 |
Reduced Methylprednisolone Clearance Causing Prolonged Pharmacodynamics in a Healthy Subject Was Not Associated With CYP3A5*3 Allele or a Change in Diet Composition
|
Lee, Su-Jun
|
|
2006
|
46 |
5 |
p. 515-526
|
artikel
|
| 9 |
Ritonavir Has Minimal Impact on the Pharmacokinetic Disposition of a Single Dose of Bupropion Administered to Human Volunteers
|
Hesse, Leah M.
|
|
2006
|
46 |
5 |
p. 567-576
|
artikel
|
| 10 |
The Effect of Montelukast on Nasal Mucociliary Clearance
|
Saieed, Waffaa N.
|
|
2006
|
46 |
5 |
p. 588-590
|
artikel
|
Tijdschrift beschrijving